维普中文期刊产品整合服务
10篇 您的检索式:作者名="Brito AS"
    题名 作者 年代 出处 被引量
1Nosocomial infections in a neonatal intensive care unit:incidence and risk factors显示文摘Nagata E Brito AS Matsuo T 2002Am J Infect Control2002,30,1:1
2Nosocomial infections in a neonatal intensive care unit: incidence and risk factors 显示文摘Nagata E Brito AS Matsuo T 2002Am J Infect Control2002,30,1:1
3Nosocomial infections in a neonatal intensive care unit :Incidence and risk factors显示文摘Nagata E Brito AS Matsuo T 2002Am J Infect Control2002,30,1:1
4Bilirubin-induced immunostimulant effects and toxicity vary with neural cell type and maturation state显示文摘Falcao AS Fernandes A Brito MA 2006Acta Neuropathol2006,112,1:1
5Nosocomial infections in a neonatal intensive care unit:incidence and risk factors显示文摘Nagata E Brito AS Matsuo TL 2002Am J Infect Control2002,30,1:1
6Apoptosis and impairment of neurite network by short exposure of immature rat cortical neurons to unconjugated bilirubin increase with cell differentiation and are additionally enhanced by an inflammatory stimulus显示文摘Falcao AS Silva RF Pancadas S Fernandes A Brito MA Brites D 2007J Neurosci Res2007,85,6:1
7A heparin-like glycosaminoglycan from shrimp containing high levels of 3-O-sulfated D-glucosamine groups in an unusual trisaccharide sequence显示文摘CHAVANTE S F BRITO AS LIMA M 2014Carbohydr Res2014,390,:1
8Restorative Man- agement of Severely Ankylosed Primary Molars 显示文摘Moura MS Pontes AS Brito MHSF 2015Journal of Dentistry for Children2015,82,1:1
9Bilirubin-induced immunostimulant effects and toxicity vary with neural cell type and maturation state 显示文摘Falcao AS Femandes A Brito MA 2006Acta Neuropathol2006,112,1:1
10Highlighting COVID-19:What the imaging exams show about the disease显示文摘Coronavirus disease 2019(COVID-19),a global emergency,is caused by severe acute respiratory syndrome coronavirus 2.The gold standard for its diagnosis is the reverse transcription polymerase chain reaction,but considering the high number of infected people,the low availability of this diagnostic tool in some contexts,and the limitations of the test,other tools that aid in the identification of the disease are necessary.In this scenario,imaging exams such as chest X-ray(CXR)and computed tomography(CT)have played important roles.CXR is useful for assessing disease progression because it allows the detection of extensive consolidations,besides being a fast and cheap method.On the other hand,CT is more sensitive for detecting lung changes in the early stages of the disease and is also useful for assessing disease progression.Of note,ground-glass opacities are the main COVID-19-related CT findings.Positron emission tomography combined with CT can be used to evaluate chronic and substantial damage to the lungs and other organs;however,it is an expensive test.Lung ultrasound(LUS)has been shown to be a promising technique in that context as well,being useful in the screening and monitoring of patients,disease classification,and management related to mechanical ventilation.Moreover,LUS is an inexpensive alternative available at the bedside.Finally,magnetic resonance imaging,although not usually requested,allows the detection of pulmonary,cardiovascular,and neurological abnormalities associated with COVID-19.Furthermore,it is important to consider the challenges faced in the radiology field in the adoption of control measures to prevent infection and in the follow-up of post-COVID-19 patients.Lorena Sousa de Carvalho Ronaldo Teixeira da Silva Júnior Bruna Vieira Silva Oliveira Yasmin Silva de Miranda Nara Lúcia Fonseca Rebouças Matheus Sande Loureiro Samuel Luca Rocha Pinheiro Regiane Santos da Silva Paulo Victor Silva Lima Medrado Correia Maria José Souza Silva Sabrina Neves Ribeiro Filipe Antônio França da Silva Breno Bittencourt de Brito Maria Luísa Cordeiro Santos Rafael Augusto Oliveira Sodré Leal Márcio Vasconcelos Oliveira Fabrício Freire de Melo 2021World Journal of Radiology2021,13,5:0
返回顶部 每页显示:
共1页 首页 上一页 第1页 下一页 末页 /1 跳转

网站首页 | 关于我们 | 联系我们 | 产品服务 | 客服中心 | 广告服务 | 版权声明 | 网站联盟 | 友情链接 | 售卡网点

版权所有© 渝B2-20050021-1 渝公网安备 50019002500403号 违法和不良信息举报中心

互联网出版许可证 新出网证(渝)字10号 全国400电话 - 免长途话费